Fenofibric Acid (Alembic Pharmaceuticals Limited)
Welcome to the PulseAid listing for the Fenofibric Acid drug offered from Alembic Pharmaceuticals Limited. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Limited |
NON-PROPRIETARY NAME: | Fenofibric Acid |
SUBSTANCE NAME: | FENOFIBRIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-15 |
END MARKETING DATE: | 0000-00-00 |
Fenofibric Acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Fenofibric Acid from Alembic Pharmaceuticals Limited |
LABELER NAME: | Alembic Pharmaceuticals Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 45(mg/1) |
START MARKETING DATE: | 2017-05-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 46708-244_c880d43a-fa8c-4f7a-a488-419bae7cc311 |
PRODUCT NDC: | 46708-244 |
APPLICATION NUMBER: | ANDA208705 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers: